Orchard Therapeutics Receives Swissmedic Approval for Libmeldy in Early-onset MLD tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Gene therapy leader Orchard Therapeutics plc (ORTX) announced Monday the Swiss Agency for Therapeutic Products (Swissmedic) has approved Libmeldy (atidarsagene autotemcel), a hematopoietic stem cell (HSC) gene therapy, for the treatment of early-onset metachromatic leukodystrophy (MLD).
On November 1, Switzerland implemented new criteria for blood donation that now allows gay, bisexual and other men who have sex with men (gbMSM) to participate in donating blood under the same rules as heterosexual individuals. The updated criteria require that all potential donors, regardless of sexual orientation, undergo a four-month waiting period following their…
First Three Countries Listed as WHO Regulatory Authorities miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.